|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 76.23 EUR | -0.33% |
|
+0.55% | -7.85% |
| 11/07 | Sanofi Receives Fda Approval for Subcutaneous Sarclisa Escena Administered Via On-Body Injector | CI |
| 11/07 | Sanofi Wins US FDA Approval for Subcutaneous Sarclisa Escena in Multiple Myeloma | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 77.95 | 77.95 | 82.58 |
| Spread/Res. | -2.21% | -2.21% | -7.69% |
| Spread/Supp. | +5.16% | +5.16% | +4.28% |
| Support | 72.49 | 72.49 | 73.1 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- SAN Stock
- Charts Sanofi
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
